ロード中...
Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease
AIMS: Both rituximab and plasmapheresis can be associated in the treatment of immune-mediated kidney diseases. The real impact of plasmapheresis on rituximab pharmacokinetics is unknown. The aim of this study was to compare rituximab pharmacokinetics between patients requiring plasmapheresis and oth...
保存先:
| 主要な著者: | , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Blackwell Science Inc
2013
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3853532/ https://ncbi.nlm.nih.gov/pubmed/23432476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12098 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|